Lei Li

Lei Li

Auto-generated profile, based on publicly available information

Lei Li

Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 119 South 4th Ring West Road, Fengtai District, Beijing, China 100070

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2025 in Circulation
Verified
Journal Article
Closed access
FGFeng Gao
Feng Gao
XTXu Tong
Xu Tong
MWMing Wei
Ming Wei
XYXiaoxi Yao
Xiaoxi Yao
LLLei Li
Lei Li
OGon behalf of the ANGEL-REBOOT Study Group
on behalf of the ANGEL-REBOOT Study Group
BACKGROUND: The long-term benefits of bailout intracranial angioplasty or stenting (BAOS) after thrombectomy in patients with acute large vessel occlusion remain unclear. This study compared BAOS with standard therapy in patients with large vessel occlusion with unsuccessful recanalization (expanded Thrombolysis In Cerebral Infarction score 0–2a) or >70% residual stenosis after thrombectomy. METHODS: ANGEL-REBOOT (Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel Occlusion) was a multicenter, open-label, blinded–end point, randomized trial conducted across 36 Chinese hospitals. Patients ≥18 years of age with anterior or posterior circulation large vessel occlusion within 24 hours of stroke onset were enrolled. After identification of thrombectomy failure or high-grade residual stenosis, patients were randomly assigned to the BAOS group (intervention) or the standard therapy group (control), in which thrombectomy was continued or terminated. The use of tirofiban was permitted in both groups during and after the procedure. In the intention-to-treat population, the primary outcome was analyzed using an assumption-free ordinal analysis (Wilcoxon-Mann-Whitney test) to compare the modified Rankin Scale scores (ordinal variable ranging from 0 to 6) between groups at 1-year follow-up, from which the generalized odds ratio was derived. Secondary outcomes included stroke recurrence in the treated artery and all-cause mortality within 1 year, analyzed using Cox proportional hazards models. RESULTS: A total of 348 patients were randomly assigned (176 to the BAOS group and 172 to the standard therapy group) and followed for 90 days, from December 19, 2021, to June 2, 2023. Of these, 326 patients (166 in the BAOS group and 160 in the standard therapy group) completed the 1-year follow-up. Compared with standard therapy, BAOS significantly improved the 1-year modified Rankin Scale score distribution (generalized odds ratio, 1.34 [95% CI, 1.05–1.73]; P =0.02). Fewer stroke recurrences in the treated artery occurred in the BAOS group than in the standard therapy group (7 of 166 [4%] versus 21 of 160 [13%]; hazard ratio, 0.30 [95% CI, 0.13–0.71]; P =0.006). One-year mortality rates were similar between groups (25 of 166 [15%] versus 27 of 160 [17%]; hazard ratio, 0.87 [95% CI, 0.50–1.50]). CONCLUSIONS: Among Chinese patients with large vessel occlusion with unsuccessful recanalization or high-grade residual stenosis after thrombectomy, BAOS was associated with reduced disability and stroke recurrence after 1 year compared with standard therapy. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05122286.

1 September 2025 in Stroke
Verified
Journal Article
Closed access
LLLei Li
Lei Li
SSShuang Song
Shuang Song
DMDa-Peng Mo
Da-Peng Mo
XTXu Tong
Xu Tong
ZMZhongrong Miao
Zhongrong Miao
AGANGEL-REBOOT Study Group
ANGEL-REBOOT Study Group
BACKGROUND: Early reocclusion following successful recanalization through mechanical thrombectomy is linked to poor clinical outcomes in patients with stroke with intracranial atherosclerotic occlusion (ICAS-O). However, the factors influencing early reocclusion remain inadequately understood. This study is a post hoc analysis of 24-hour reocclusion in patients with successfully recanalized ICAS-O from a multicenter trial. METHODS: Patients with successfully recanalized ICAS-O were selected from the ANGEL-REBOOT trial (Randomized Study of Bailout Intracranial Angioplasty Following Thrombectomy for Acute Large Vessel Occlusion). Reocclusion was defined as a 24-hour arterial occlusive lesion score of 0 to 1, determined by magnetic resonance or computed tomography angiography. Possible factors associated with early reocclusion were screened through univariable analysis, and then, multivariable logistic regression was used to identify independent factors associated with early reocclusion. RESULTS: Among the 348 patients in the ANGEL-REBOOT trial, 21 could not be diagnosed with ICAS-O, 14 failed recanalization by the end of the procedure, and 14 had no follow-up angiography data. Finally, a total of 299 subjects were included, with a median age of 63 (interquartile range, 55–69) years, and 77 of 299 (25.75%) were female patients. The 24-hour reocclusion rate was 9.7% (29/299). Through backward elimination, 3 independent factors remained in the final multivariable logistic regression model. Specifically, puncture-to-recanalization time (per hour increase: odds ratio, 1.80 [95% CI, 1.31–2.47]) was positively associated with reocclusion, while general anesthesia (odds ratio, 0.25 [95% CI, 0.10–0.65]) and a postprocedural expanded Thrombolysis in Cerebral Infarction score of 2c-3 (odds ratio, 0.35 [95% CI, 0.14–0.85]) were negatively associated with reocclusion. Compared with patients without reocclusion, those with reocclusion had significantly greater 90-day modified Rankin Scale scores (median 4 versus 1, Mann-Whitney U test; P <0.001). CONCLUSIONS: In patients with successfully recanalized ICAS-O, a longer puncture-to-recanalization time was associated with an increased risk of early reocclusion, while general anesthesia and a postprocedural expanded Thrombolysis in Cerebral Infarction score of 2c-3 were associated with a reduced risk of early reocclusion. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05122286.

1 January 2026 in Radiology
Verified
Journal Article
Closed access
LLLei Li
Lei Li
ZYZhaoxuan Yan
Zhaoxuan Yan
QWQi Wu
Qi Wu
HSHaoquan Sun
Haoquan Sun
JHJianjia Han
Jianjia Han
FGFeng Gao
Feng Gao
Study findings demonstrated that medical treatment alone was associated with better clinical outcomes compared with endovascular recanalization plus medical treatment in patients with symptomatic nonacute intracranial artery occlusion.

10 November 2026 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
LLLei Li
Lei Li
QWQi Wu
Qi Wu
YJYu Jiang
Yu Jiang
HSHaoquan Sun
Haoquan Sun
SQShen Qu
Shen Qu
FGFeng Gao
Feng Gao